Edgar Filing: Symmetry Medical Inc.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 17, 2013

SYMMETRY MEDICAL INC.

(Exact name of Registrant as specified in its charter)

Delaware

001-32374

35-1996126

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

3724 N State Road 15, Warsaw, Indiana 46582

(Address of Principal executive offices, including Zip Code)

(574) 268-2252

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01. Other Events

On October 17, 2013 Symmetry Medical Inc. (“the Company”) released a press release entitled, “Symmetry Medical Reports Preliminary Third Quarter 2013 Revenue of $98 Million,” in which the Company announced preliminary financial data related to its fiscal third quarter which has been impacted by operational issues. It also announced that it will update its guidance and announce its third quarter earnings in a conference call scheduled for Thursday, October 31, 2013. Further details are included in the press release, which is being furnished as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits

(d)

Exhibits

99.1	“Symmetry Medical Reports Preliminary Third Quarter 2013 Revenue of $98 Million,” Press Release issued by Symmetry Medical, Inc. dated October 17, 2013.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Symmetry Medical Inc.

	/s/ Fred L. Hite
Date: October 17, 2013	Name: Fred L. Hite
	Title: Chief Financial Officer

EXHIBIT INDEX

Exhibit No.		Description

99.1	“Symmetry Medical Reports Preliminary Third Quarter 2013 Revenue of $98 Million,” Press Release issued by Symmetry Medical, Inc. dated October 17, 2013.